Clinical Infectious Diseases

Research finds targeted screening for hepatitis C is cost-effective

Researchers at the University of Cincinnati have found that targeted screening for populations with a higher estimated prevalence for hepatitis C may be cost-effective.

Diseases, Conditions, Syndromes Apr 24, 2013 | not rated yet | 0